Multidrug-resistant and extensively drug-resistant tuberculosis: the National Institute of Allergy and Infectious Diseases Research agenda and recommendations for priority research

J Infect Dis. 2008 Jun 1;197(11):1493-8. doi: 10.1086/587904.

Authors

Anthony S Fauci¹; NIAID Tuberculosis Working Group

Collaborators

Affiliation

¹ National Institute of Allergy and Infectious Diseases, National Institutes of Health, 9000 Rockville Pike, Bldg. 31, Rm 7A05, Bethesda, MD 20892, USA.

PMID: 18426366
DOI: 10.1086/587904

No abstract available

Publication types

Research Support, N.I.H., Extramural
Review

MeSH terms

Biomedical Research / trends*
Health Policy*
Humans
National Institute of Allergy and Infectious Diseases (U.S.)*
Tuberculosis, Multidrug-Resistant / drug therapy*
Tuberculosis, Multidrug-Resistant / epidemiology*
United States / epidemiology